| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sphingosine N-acyltransferase activity | 1.79e-08 | 7 | 17 | 3 | GO:0050291 | |
| GeneOntologyMolecularFunction | sphingomyelin synthase activity | 2.05e-06 | 3 | 17 | 2 | GO:0033188 | |
| GeneOntologyMolecularFunction | ceramide phosphoethanolamine synthase activity | 2.05e-06 | 3 | 17 | 2 | GO:0002950 | |
| GeneOntologyMolecularFunction | ceramide cholinephosphotransferase activity | 2.05e-06 | 3 | 17 | 2 | GO:0047493 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 4.15e-05 | 238 | 17 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 8.35e-05 | 102 | 17 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, for other substituted phosphate groups | 1.56e-04 | 22 | 17 | 2 | GO:0016780 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 3.58e-03 | 775 | 17 | 4 | GO:0016746 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.36e-02 | 211 | 17 | 2 | GO:0016758 | |
| GeneOntologyBiologicalProcess | ceramide biosynthetic process | 2.89e-09 | 73 | 17 | 5 | GO:0046513 | |
| GeneOntologyBiologicalProcess | ceramide metabolic process | 2.65e-08 | 113 | 17 | 5 | GO:0006672 | |
| GeneOntologyBiologicalProcess | sphingolipid biosynthetic process | 3.16e-08 | 117 | 17 | 5 | GO:0030148 | |
| GeneOntologyBiologicalProcess | membrane lipid biosynthetic process | 1.38e-07 | 157 | 17 | 5 | GO:0046467 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 2.17e-07 | 172 | 17 | 5 | GO:0043604 | |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 2.43e-07 | 176 | 17 | 5 | GO:0006665 | |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 8.96e-07 | 229 | 17 | 5 | GO:0006643 | |
| GeneOntologyBiologicalProcess | sphingomyelin biosynthetic process | 3.50e-05 | 11 | 17 | 2 | GO:0006686 | |
| GeneOntologyBiologicalProcess | amide metabolic process | 4.43e-05 | 511 | 17 | 5 | GO:0043603 | |
| GeneOntologyBiologicalProcess | sphingomyelin metabolic process | 1.33e-04 | 21 | 17 | 2 | GO:0006684 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | 3.91e-04 | 813 | 17 | 5 | GO:0008610 | |
| GeneOntologyBiologicalProcess | negative regulation of blood pressure | 1.49e-03 | 70 | 17 | 2 | GO:0045776 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 1.59e-03 | 641 | 17 | 4 | GO:1901615 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 1.62e-03 | 73 | 17 | 2 | GO:0044091 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | PEX16 CERS2 ATP13A1 SGMS2 ALG3 CERS6 SOAT1 CERS3 REEP4 SGMS1 UGT2A1 | 4.26e-10 | 1293 | 17 | 11 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | PEX16 CERS2 ATP13A1 SGMS2 ALG3 CERS6 SOAT1 CERS3 REEP4 SGMS1 UGT2A1 | 4.48e-10 | 1299 | 17 | 11 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | PEX16 CERS2 ATP13A1 SGMS2 ALG3 CERS6 SOAT1 CERS3 REEP4 SGMS1 UGT2A1 | 5.62e-10 | 1327 | 17 | 11 | GO:0042175 |
| MousePheno | abnormal ceramide level | 3.90e-06 | 32 | 14 | 3 | MP:0012232 | |
| MousePheno | abnormal sphingolipid level | 7.73e-06 | 40 | 14 | 3 | MP:0012230 | |
| MousePheno | abnormal sphingomyelin level | 8.42e-05 | 14 | 14 | 2 | MP:0009823 | |
| Domain | Lag1/Lac1 | 1.03e-08 | 6 | 16 | 3 | IPR016439 | |
| Domain | TLC | 2.87e-07 | 16 | 16 | 3 | PS50922 | |
| Domain | TLC-dom | 2.87e-07 | 16 | 16 | 3 | IPR006634 | |
| Domain | TRAM_LAG1_CLN8 | 2.87e-07 | 16 | 16 | 3 | PF03798 | |
| Domain | TLC | 2.87e-07 | 16 | 16 | 3 | SM00724 | |
| Domain | Sphingomyelin_synth-like_dom | 2.06e-06 | 3 | 16 | 2 | IPR025749 | |
| Domain | PAP2_C | 2.06e-06 | 3 | 16 | 2 | PF14360 | |
| Domain | P_Acid_Pase_2/haloperoxidase | 1.30e-04 | 20 | 16 | 2 | IPR000326 | |
| Domain | PAP2 | 1.30e-04 | 20 | 16 | 2 | PF01569 | |
| Domain | Homeobox | 9.64e-04 | 234 | 16 | 3 | PF00046 | |
| Domain | HOMEOBOX_1 | 9.88e-04 | 236 | 16 | 3 | PS00027 | |
| Domain | HOX | 1.00e-03 | 237 | 16 | 3 | SM00389 | |
| Domain | Homeobox_dom | 1.02e-03 | 239 | 16 | 3 | IPR001356 | |
| Domain | HOMEOBOX_2 | 1.02e-03 | 239 | 16 | 3 | PS50071 | |
| Domain | - | 1.67e-03 | 283 | 16 | 3 | 1.10.10.60 | |
| Domain | Homeodomain-like | 2.62e-03 | 332 | 16 | 3 | IPR009057 | |
| Pathway | WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES | 1.13e-11 | 22 | 14 | 5 | M45544 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 2.27e-11 | 25 | 14 | 5 | MM15931 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 2.81e-11 | 26 | 14 | 5 | MM15892 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 2.81e-11 | 26 | 14 | 5 | M39784 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 3.45e-11 | 27 | 14 | 5 | M39863 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 3.45e-11 | 27 | 14 | 5 | MM14646 | |
| Pathway | WP_SPHINGOLIPID_PATHWAY | 6.07e-11 | 30 | 14 | 5 | M39501 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 1.85e-10 | 37 | 14 | 5 | M554 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 2.03e-08 | 92 | 14 | 5 | MM15086 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 4.35e-08 | 107 | 14 | 5 | M14857 | |
| Pathway | WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS | 1.03e-06 | 21 | 14 | 3 | M39459 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 2.33e-04 | 620 | 14 | 5 | MM15193 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE | 3.41e-04 | 28 | 14 | 2 | M42536 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 5.88e-04 | 757 | 14 | 5 | M27451 | |
| Pathway | KEGG_SPHINGOLIPID_METABOLISM | 6.65e-04 | 39 | 14 | 2 | M15955 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.18e-03 | 52 | 14 | 2 | M14171 | |
| Pubmed | 1.17e-12 | 27 | 17 | 5 | 23096701 | ||
| Pubmed | Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil. | 1.17e-12 | 27 | 17 | 5 | 25269881 | |
| Pubmed | 9.69e-10 | 5 | 17 | 3 | 26887952 | ||
| Pubmed | 1.94e-09 | 6 | 17 | 3 | 17977534 | ||
| Pubmed | 1.94e-09 | 6 | 17 | 3 | 23936132 | ||
| Pubmed | 2.55e-09 | 37 | 17 | 4 | 29044125 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 27892528 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 17982138 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 17449912 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 22106271 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 19912991 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 22641779 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 17616479 | ||
| Pubmed | 2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity. | 2.25e-07 | 2 | 17 | 2 | 30305392 | |
| Pubmed | Sphingomyelin synthases regulate protein trafficking and secretion. | 2.25e-07 | 2 | 17 | 2 | 21980337 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 19001565 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 27927984 | ||
| Pubmed | The domain responsible for sphingomyelin synthase (SMS) activity. | 2.25e-07 | 2 | 17 | 2 | 18694848 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 31847800 | ||
| Pubmed | Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism. | 2.25e-07 | 2 | 17 | 2 | 33545384 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 31596951 | ||
| Pubmed | Loss of ceramide synthase 3 causes lethal skin barrier disruption. | 2.25e-07 | 2 | 17 | 2 | 22038835 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 22209789 | ||
| Pubmed | Ablation of ceramide synthase 2 strongly affects biophysical properties of membranes. | 2.25e-07 | 2 | 17 | 2 | 22231783 | |
| Pubmed | Sphingomyelin synthases 1 and 2 exhibit phosphatidylcholine phospholipase C activity. | 2.25e-07 | 2 | 17 | 2 | 34774525 | |
| Pubmed | Sphingomyelin synthases regulate production of diacylglycerol at the Golgi. | 2.25e-07 | 2 | 17 | 2 | 18370930 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 16508036 | ||
| Pubmed | Regulation of meiotic telomere dynamics through membrane fluidity promoted by AdipoR2-ELOVL2. | 3.52e-07 | 29 | 17 | 3 | 38485951 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 25605874 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 37586586 | ||
| Pubmed | Identification of a family of animal sphingomyelin synthases. | 6.74e-07 | 3 | 17 | 2 | 14685263 | |
| Pubmed | Sphingomyelin maintains the cutaneous barrier via regulation of the STAT3 pathway. | 6.74e-07 | 3 | 17 | 2 | 35230716 | |
| Pubmed | Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. | 6.74e-07 | 3 | 17 | 2 | 20406683 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 34915026 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 22580896 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 31958434 | ||
| Pubmed | SMS regulates the expression and function of P-gp and MRP2 in Caco-2 cells. | 1.35e-06 | 4 | 17 | 2 | 27394416 | |
| Pubmed | SIRT3 Deacetylates Ceramide Synthases: IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY. | 1.35e-06 | 4 | 17 | 2 | 26620563 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 22688512 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 12912983 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 12297269 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 23538298 | ||
| Pubmed | Modulation of ceramide metabolism in mouse primary macrophages. | 1.35e-06 | 4 | 17 | 2 | 20637730 | |
| Pubmed | Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. | 2.25e-06 | 5 | 17 | 2 | 15823095 | |
| Pubmed | SMS2 deficiency impairs PKCδ-regulated B cell tolerance in the germinal center. | 2.25e-06 | 5 | 17 | 2 | 34469734 | |
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 31971349 | ||
| Pubmed | Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis. | 6.29e-06 | 8 | 17 | 2 | 36543979 | |
| Pubmed | 1.23e-05 | 11 | 17 | 2 | 23689133 | ||
| Pubmed | 3.83e-05 | 19 | 17 | 2 | 28369476 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 6.70e-05 | 468 | 17 | 4 | 31056421 | |
| Pubmed | 7.15e-05 | 952 | 17 | 5 | 38569033 | ||
| Pubmed | 8.22e-05 | 176 | 17 | 3 | 28692057 | ||
| Pubmed | 1.11e-04 | 32 | 17 | 2 | 24706805 | ||
| Pubmed | 1.41e-04 | 568 | 17 | 4 | 37774976 | ||
| Pubmed | 1.87e-04 | 1168 | 17 | 5 | 19946888 | ||
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | 2.10e-04 | 630 | 17 | 4 | 36949045 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.13e-04 | 1201 | 17 | 5 | 35696571 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 2.15e-04 | 1203 | 17 | 5 | 29180619 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 3.09e-04 | 697 | 17 | 4 | 28298427 | |
| Pubmed | 3.38e-04 | 1327 | 17 | 5 | 32694731 | ||
| Pubmed | 3.80e-04 | 296 | 17 | 3 | 34186245 | ||
| Interaction | TSPAN15 interactions | 2.51e-06 | 276 | 17 | 5 | int:TSPAN15 | |
| Interaction | TTYH1 interactions | 3.78e-06 | 300 | 17 | 5 | int:TTYH1 | |
| Interaction | TCTN3 interactions | 6.37e-06 | 334 | 17 | 5 | int:TCTN3 | |
| Interaction | VIPR2 interactions | 1.80e-05 | 194 | 17 | 4 | int:VIPR2 | |
| Interaction | ATP2A1 interactions | 2.00e-05 | 423 | 17 | 5 | int:ATP2A1 | |
| Interaction | LPAR1 interactions | 2.45e-05 | 210 | 17 | 4 | int:LPAR1 | |
| Interaction | SEC62 interactions | 4.71e-05 | 506 | 17 | 5 | int:SEC62 | |
| Interaction | CCR6 interactions | 5.41e-05 | 89 | 17 | 3 | int:CCR6 | |
| Interaction | POMK interactions | 6.63e-05 | 271 | 17 | 4 | int:POMK | |
| Interaction | C3AR1 interactions | 7.66e-05 | 100 | 17 | 3 | int:C3AR1 | |
| Interaction | OPRL1 interactions | 8.13e-05 | 102 | 17 | 3 | int:OPRL1 | |
| Interaction | SYNGR1 interactions | 9.90e-05 | 109 | 17 | 3 | int:SYNGR1 | |
| Interaction | TCTN2 interactions | 1.03e-04 | 304 | 17 | 4 | int:TCTN2 | |
| Interaction | DIO3 interactions | 1.53e-04 | 22 | 17 | 2 | int:DIO3 | |
| Interaction | ELOVL4 interactions | 1.59e-04 | 128 | 17 | 3 | int:ELOVL4 | |
| Interaction | BIK interactions | 1.75e-04 | 132 | 17 | 3 | int:BIK | |
| Interaction | TMT1A interactions | 1.96e-04 | 359 | 17 | 4 | int:TMT1A | |
| Interaction | ELOVL5 interactions | 2.07e-04 | 364 | 17 | 4 | int:ELOVL5 | |
| Interaction | HSD3B7 interactions | 2.59e-04 | 386 | 17 | 4 | int:HSD3B7 | |
| Interaction | HSD17B11 interactions | 2.69e-04 | 390 | 17 | 4 | int:HSD17B11 | |
| Interaction | C5AR1 interactions | 2.75e-04 | 154 | 17 | 3 | int:C5AR1 | |
| Interaction | RHOA interactions | 3.07e-04 | 1199 | 17 | 6 | int:RHOA | |
| Interaction | OTULINL interactions | 3.11e-04 | 405 | 17 | 4 | int:OTULINL | |
| Interaction | CRELD1 interactions | 3.25e-04 | 163 | 17 | 3 | int:CRELD1 | |
| Interaction | RPN1 interactions | 4.38e-04 | 814 | 17 | 5 | int:RPN1 | |
| Interaction | P2RY1 interactions | 6.49e-04 | 45 | 17 | 2 | int:P2RY1 | |
| Interaction | RANBP1 interactions | 6.90e-04 | 211 | 17 | 3 | int:RANBP1 | |
| Interaction | SCN3B interactions | 7.19e-04 | 214 | 17 | 3 | int:SCN3B | |
| Interaction | CA9 interactions | 7.29e-04 | 215 | 17 | 3 | int:CA9 | |
| Interaction | RETREG3 interactions | 8.00e-04 | 222 | 17 | 3 | int:RETREG3 | |
| Interaction | CADM4 interactions | 8.01e-04 | 50 | 17 | 2 | int:CADM4 | |
| Interaction | VAMP1 interactions | 9.69e-04 | 55 | 17 | 2 | int:VAMP1 | |
| Interaction | GYPB interactions | 1.00e-03 | 56 | 17 | 2 | int:GYPB | |
| Interaction | VSTM1 interactions | 1.00e-03 | 56 | 17 | 2 | int:VSTM1 | |
| Interaction | PEX16 interactions | 1.23e-03 | 62 | 17 | 2 | int:PEX16 | |
| Interaction | TXNDC15 interactions | 1.31e-03 | 64 | 17 | 2 | int:TXNDC15 | |
| Interaction | ERGIC1 interactions | 1.32e-03 | 264 | 17 | 3 | int:ERGIC1 | |
| Interaction | SERP1 interactions | 1.39e-03 | 66 | 17 | 2 | int:SERP1 | |
| Interaction | EFNA5 interactions | 1.48e-03 | 68 | 17 | 2 | int:EFNA5 | |
| Interaction | PTPRE interactions | 1.52e-03 | 69 | 17 | 2 | int:PTPRE | |
| Interaction | TNFSF18 interactions | 1.52e-03 | 69 | 17 | 2 | int:TNFSF18 | |
| Interaction | SLC30A8 interactions | 1.61e-03 | 71 | 17 | 2 | int:SLC30A8 | |
| Interaction | GPR17 interactions | 1.61e-03 | 283 | 17 | 3 | int:GPR17 | |
| Interaction | DNAJC25 interactions | 1.63e-03 | 284 | 17 | 3 | int:DNAJC25 | |
| Interaction | SLC2A12 interactions | 1.65e-03 | 72 | 17 | 2 | int:SLC2A12 | |
| Interaction | VSIG1 interactions | 1.65e-03 | 72 | 17 | 2 | int:VSIG1 | |
| Interaction | LEPROTL1 interactions | 1.89e-03 | 77 | 17 | 2 | int:LEPROTL1 | |
| Interaction | SLC39A12 interactions | 2.04e-03 | 80 | 17 | 2 | int:SLC39A12 | |
| Interaction | MFSD14B interactions | 2.04e-03 | 80 | 17 | 2 | int:MFSD14B | |
| Interaction | GPR21 interactions | 2.09e-03 | 81 | 17 | 2 | int:GPR21 | |
| Interaction | PTPN5 interactions | 2.40e-03 | 87 | 17 | 2 | int:PTPN5 | |
| Interaction | PTAR1 interactions | 2.40e-03 | 87 | 17 | 2 | int:PTAR1 | |
| Interaction | GPAA1 interactions | 2.46e-03 | 88 | 17 | 2 | int:GPAA1 | |
| Interaction | PTH1R interactions | 2.46e-03 | 88 | 17 | 2 | int:PTH1R | |
| Interaction | CXCL16 interactions | 2.51e-03 | 89 | 17 | 2 | int:CXCL16 | |
| Interaction | ACKR2 interactions | 2.57e-03 | 90 | 17 | 2 | int:ACKR2 | |
| Interaction | TMEM128 interactions | 2.57e-03 | 90 | 17 | 2 | int:TMEM128 | |
| Interaction | ASGR2 interactions | 2.62e-03 | 91 | 17 | 2 | int:ASGR2 | |
| Interaction | CYB5R3 interactions | 2.67e-03 | 338 | 17 | 3 | int:CYB5R3 | |
| Interaction | ERGIC3 interactions | 2.72e-03 | 340 | 17 | 3 | int:ERGIC3 | |
| Interaction | GPR12 interactions | 2.74e-03 | 93 | 17 | 2 | int:GPR12 | |
| Interaction | ADGRG5 interactions | 2.74e-03 | 93 | 17 | 2 | int:ADGRG5 | |
| Interaction | KIR2DL4 interactions | 2.80e-03 | 94 | 17 | 2 | int:KIR2DL4 | |
| GeneFamily | CERS class homeoboxes | 4.46e-09 | 6 | 12 | 3 | 530 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 2.92e-06 | 681 | 17 | 6 | M5314 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 3.50e-06 | 703 | 17 | 6 | MM1055 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | 8.81e-05 | 1242 | 17 | 6 | M1920 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | 1.21e-04 | 1316 | 17 | 6 | MM1052 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-07 | 145 | 17 | 4 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 1.81e-03 | 110 | 17 | 2 | EFO_0803335 | |
| Disease | response to xenobiotic stimulus | 4.84e-03 | 182 | 17 | 2 | GO_0009410 | |
| Disease | S-6-hydroxywarfarin measurement | 1.86e-02 | 368 | 17 | 2 | EFO_0803326 | |
| Disease | free androgen index | 1.92e-02 | 374 | 17 | 2 | EFO_0007005 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YVWYFHTLPYLLWAM | 361 | Q92685 | |
| LWCLDEYWYYSVFTL | 256 | Q9HD20 | |
| TLPLWATYYSYRYDW | 96 | P50052 | |
| WYYMIELSFYWSLLF | 181 | Q96G23 | |
| PSQYWYYILEMSFYW | 176 | Q8IU89 | |
| YYILELSFYWSLMFS | 181 | Q6ZMG9 | |
| WFPFYYEIKMAFVLW | 61 | Q9H6H4 | |
| MDYLPTWQKIYFYSW | 321 | Q9Y5Y5 | |
| EWAFTSLSYLYKYLW | 146 | O75691 | |
| DWLYYYAYKDFLWFF | 426 | P35610 | |
| RKDAYMFWWLYYATN | 46 | Q9HB40 | |
| YYITTRLFWWYHSMA | 281 | Q8NHU3 | |
| IYWYLSEFLYAWLMS | 521 | Q5VZE5 | |
| EFYYWDSYWVMEGLL | 171 | O43280 | |
| AYYITTRLFWWYHTM | 336 | Q86VZ5 | |
| WTYYLNWCSDIFYMF | 191 | A6NGA9 | |
| YMFETLWKSWDSYYS | 221 | P0DTE4 |